Press releases

Scroll to content

2026

February 25

GBL exits its position in Umicore in the context of portfolio simplification, one of the group’s key strategic priorities

February 09

GBL invests in Rayner, a leading ophthalmic MedTech specialist, as part of the group’s mid-term strategy execution

January 14

Successful placement of GBL’s €500m bond issuance with a 10-year maturity

January 12

GBL further strengthens its investment team to support the execution of the mid-term strategy

December 24

Sienna Investment Managers

November 18

GBL successfully completes the sale of 19.6m shares of Umicore

November 06

Results as of September 30, 2025

November 03

Portfolio simplification with significant monetization of GBL Capital

October 02

Sienna Investment Managers

September 24

GBL Capital

July 31

HY Report 2025
Progress on mid-term objectives: value creation from private assets & enhanced returns

May 27

Report on payments to governments

May 12

GBL continues its share buyback program

May 02

Results as of March 31, 2025

May 02

Extraordinary and Ordinary General Shareholders’ Meetings of May 2, 2025

April 28

Transparency declaration

April 02

Extraordinary and Ordinary General Shareholders’ Meetings of May 2, 2025

April 02

Publication of the 2024 Annual Report

March 13

Sagard

March 13

Results as of December 31, 2024

March 13

New governance at GBL

March 06

GBL successfully completes the sale of 8.5 million shares of SGS SA

February 21

Imerys